MyAverix Finance
F · Healthcare
SAREUM HLDGS LS-0125 (RYH0)
Biotechnology
SAREUM HLDGS LS-0125 (RYH0) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $22.78M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for RYH0
SAREUM HLDGS LS-0125 (RYH0) — FAQ
What is SAREUM HLDGS LS-0125's market cap?
SAREUM HLDGS LS-0125 (RYH0) has a reported market cap of $22.78M (data as of 2026-03-30).
What is RYH0's P/E ratio?
The price-to-earnings (P/E) ratio for SAREUM HLDGS LS-0125 (RYH0) is 18.00 (data as of 2026-03-30).
Does SAREUM HLDGS LS-0125 pay a dividend?
Dividend yield is not available in the current snapshot for SAREUM HLDGS LS-0125 (RYH0). Check the MyAverix Finance app for the latest dividend data.
What sector is SAREUM HLDGS LS-0125 in?
SAREUM HLDGS LS-0125 (RYH0) is classified in the Healthcare sector (Biotechnology industry).
What exchange is RYH0 listed on?
RYH0 is listed on F.
What is SAREUM HLDGS LS-0125's net margin?
SAREUM HLDGS LS-0125 (RYH0) reports a net margin of 0.0% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.